MedTrace Logo

Treatment of Mild and Subthreshold Depressive Disorders

NCT00226642 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 369

Last updated 2005-09-27

No results posted yet for this study

Summary

The purpose of this study is to determine the efficacy of a SSRI, cognitive-bahavioral-therapy and a free choice between SSRI and CBT in a sample of primary care patients suffering from mild to moderate depression.

Hypotheses:

* SSRI is superior to placebo
* CBT is superior to a non-specific supporting group therapy

Conditions

Interventions

DRUG

Sertralin

BEHAVIORAL

Cognitive-behavioral therapy

DRUG

Placebo

BEHAVIORAL

Non-specific supporting group therapy

Sponsors & Collaborators

  • Ludwig-Maximilians - University of Munich

    lead OTHER

Principal Investigators

  • Ulrich Hegerl, Prof, MD · LMU, Department of Psychiatry

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00226642 on ClinicalTrials.gov